SCGCRC
@socalguresearch
Researchers from around Southern California with interests in #kidneycancer, #bladdercancer, #prostatecancer, #testiscancer & other GU malignancies.
ID: 1644037712004141057
06-04-2023 18:02:00
36 Tweet
134 Followers
71 Following
EV-pembrolizumab approved in US based on EV-103 results Daniel Petrylak Christopher Hoimes et al. Great news for patients w cisplatin ineligible #bladdercancer! Bladder Cancer Advocacy Network @SeagenGlobal onclive.com/view/fda-appro…
Honored to participate in this discussion UroToday.com Alicia Morgans, MD, MPH-Enfortumab Vedotin (EV) +Pembrolizumab received accelerated approval by the U.S. FDA for cisplatin-ineligible patients with advanced #urothelialcarcinoma based on high ORR and DOR in EV103 Phase I/II cohorts A &
(6/7) We are thrilled to have the Uromigos, Tom Powles Barts Cancer Centre & Brian Rini, MD Vanderbilt University serving as "external advisors" to the group - hoping they will bring lots of wisdom to our 1st meeting!
We are excited to have Rana McKay, MD, FASCO joining us for the 1st live meeting of the #SCGCRC tomorrow!
1st Southern California Genitourinary Research Collaborative meeting just started! #SCGCRC COH: Sumanta K. Pal, MD, FASCO Tanya Dorff USC: Sia Daneshmand, M.D. Dr. D’Souza UCI: Arash Rezazadeh Dr. Mar UCLA: Amar Kishan Dr. Dakraki Cedars: Jun Gong Hyung Kim UCSD: Rana McKay, MD, FASCO DrBagrodia
Starting the first #SCGCRC meeting with Sia Daneshmand, M.D. and Dr. Anishka D'souza's @KeckMedUSC research/trial portfolio.
From City of Hope group Sumanta K. Pal, MD, FASCO, Tanya Dorff, and Abhishek Tripathi highlighting the exciting phase I CAR-T and microbiome trials.
Dr. Nataliya Mar and Arash Rezazadeh from UCI Health are discussing their early phase trials along with radiopharmaceutical studies and basic science collaborations.
Julie Gralow ASCO ESMO - Eur. Oncology Toni Choueiri, MD FabriceAndre I assume ESPN covering? This is exciting stuff! I hung up my cletes a long time ago, but perhaps its time to dust them off? SCGCRC Nataliya Mar Arash Rezazadeh Neeraj Agarwal, MD, FASCO Petros Grivas Jun Gong Nazli Dizman Brian Shuch, MD
Kudos to Dr. Kimryn Rathmell & National Cancer Institute for developing the #NationalCancerPlan, a thoughtful & detailed roadmap for our approach to #cancer #research. The experience #DrBertagnolli has as both a practicing clinician & physician scientist shows in this comprehensive document. Fully agree
If you will be at #AACR23, don't miss this stellar session w Vivek Subbiah, MD! Sandip Patel MD FASCO Dr. Ravi Salgia Razelle Kurzrock, MD @jacobadashek Stacy W. Gray Toni Choueiri, MD Neeraj Agarwal, MD, FASCO Petros Grivas Ishwaria Subbiah, MD MS FASCO
Dear colleagues, It is an honor to announce a remarkable collaboration between The OncoAlert 🚨Network, Cancer Discovery and The #AACR23 Meeting‼️ This special collaboration has been carefully crafted to enrich and enhance the experience of all attendees of the AACR 🇺🇸meeting and
Uromigos go to Hollywood starting today Uromigos.org . Papillary renal cancer, management of upper tract disease, FDA accelerated FDA approval of EV & pembro, adjuvant vs neoadjuvant ADT in prostate cancer. Sumanta K. Pal, MD, FASCO & Alexandra Drakaki and more.
How cool is it to have the @uromigos in your hometown? Words cannot describe. Looking forward to seeing what Brian Rini, MD & Tom Powles release over the next couple of days from their #Hollywood tour! DrBagrodia Amar Kishan Rana McKay, MD, FASCO Abhishek Tripathi Brian Shuch, MD
We are proud of Southern California phenom Sanam Ladi Seyedian (starting soon at Vanderbilt Health!) and her stellar mentor Sia Daneshmand, M.D. USC Urology. So many terrific opportunities for mentorship in beautiful Southern California!